Clinical observation of amitriptyline combined with Xiaoyao Powder in the treatment of postpartum depression
10.3760/cma.j.issn.1008-6706.2019.19.007
- VernacularTitle: 阿米替林联合逍遥散加味治疗产后抑郁症的临床疗效观察
- Author:
Jiang CAO
1
;
Dongsheng ZHOU
2
;
Yan ZHANG
1
;
Guidong ZHU
1
;
Nahua YUAN
1
;
Chang YU
2
Author Information
1. The Sixth Disease Areas, the Second People's Hospital of Lishui, Lishui, Zhejiang 323000, China
2. Department of Psychiatry, Kangning Hospital, Ningbo, Zhejiang 315135, China
- Publication Type:Journal Article
- Keywords:
Depression, postpartum;
Quality of life;
Amitriptyline;
Xiaoyao scattered flavor
- From:
Chinese Journal of Primary Medicine and Pharmacy
2019;26(19):2332-2335
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical effect of amitriptyline combined with Xiaoyao Powder in the treatment of postpartum depression.
Methods:From January 2018 to February 2018, 128 patients with postpartum depression in the Second People's Hospital of Lishui were selected.The patients were randomly divided into observation group and control group according to the digital table, with 64 cases in each group.The observation group was treated with Chinese and western medicine (amitriptyline combined with Xiaoyao Powder), and the control group was treated with amitriptyline alone.The self-rating anxiety scale (SAS), self-rating depression scale (SDS) score, and the concise health survey scale (SF-36) score before and after treatment were compared between the two groups.
Results:The SDS scores of the two groups were decreased after treatment (t=4.564, 3.656, P=0.012, 0.027), and the SDS score of the observation group was lower than that of the control group, the difference was statistically significant (P=0.035). The SDS scores had no statistically significant difference between the two groups before treatment (P=0.961). The SAS scores in the two groups were decreased after treatment (t=4.352, 3.432, P=0.015, 0.029). The SAS score of the observation group was lower than that of the control group, and the difference was statistically significant (t=3.021, P=0.038). After treatment, the scores of SF-36 in the observation group were significantly increased (all P<0.05), and the comparison of various indicators: emotional function (t=2.951, P=0.048), vitality (t=3.012, P=0.042), mental health (t=3.131, P=0.043), social function (t=2.967, P=0.048), physical pain (3.320, P=0.039), physiological function (t=3.467, P=0.038), physiological function (t=3.986, P=0.035), overall health (t=4.045, P=0.021), which had statistically significant differences compared with the control group.
Conclusion:Amitriptyline combined with Xiaoyao Powder in the treatment of postpartum depression can significantly improve the quality of life and improve the anxiety and depressive symptoms of patients, which is better than amitriptyline alone.
